Data analysis of PD-1 antibody in the treatment of melanoma patients.

Clicks: 320
ID: 104594
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #49 of 180 articles by views in Data in brief

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 180 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Data presented in this article are supplementary materials to the research article entitled "IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma". Data for melanoma patients who did not receive anti-PD-1 treatment were obtained from Tianjin Medical University Cancer Institute & Hospital from February 1981 to May 2013. Kaplan-Meier was used for survival analysis. RNA sequencing data from 28 melanoma patients receiving anti-PD-1 therapy were download from GEO database (GSE78220). Cluster analysis of RNA expression was performed using R (package pheatmap). The difference of PD-L1 expression was analysed by the Boxplot (R ggplot2 package). Differences between each group were analyzed by Fisher exact test. Information of 13 melanoma patients who had failed prior chemotherapy and treated in the Tianjin Medical University Cancer Institute & Hospital between July 2015 and December 2018 was collected. The response was captured by Response Evaluation Criteria in Solid Tumors 1.1 (RECIST 1.1).
Reference Key
li2020datadata Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Li, Ting;Zhang, Chao;Zhao, Gang;Zhang, Xinwei;Hao, Mengze;Hassan, Shafat;Zhang, Min;Zheng, Hong;Yang, Da;Liu, Liang;Mehraein-Ghomi, Farideh;Bai, Xu;Chen, Kexin;Zhang, Wei;Yang, Jilong;
Journal Data in brief
Year 2020
DOI
10.1016/j.dib.2020.105523
URL
Keywords
melanoma immunotherapy igfbp2 pd-1/pd-l1

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.